Associate Professor Jasmina Grujić, MD, PhD, is Director of the Institute for Blood Transfusion of Vojvodina and Associate Professor at the Faculty of Medicine, University of Novi Sad, Serbia. She earned her MD (2003), specialization in transfusion medicine (2010), and PhD in clinical medicine (2015) at the same institution. Since 2025, she holds a subspecialization in Clinical Transfusion Medicine.
Her expertise includes transfusion medicine, donor screening, immunohematology, transfusion-transmitted infections, and transfusion immunology. She is actively involved in HLA genotyping, hemovigilance, donor health, iron metabolism, clinical transfusion outcomes, and infection risk management. Her research further includes platelet function and hemostasis, transfusion-related immunomodulation (TRIM), antimicrobial resistance, next-generation sequencing in transfusion safety, and pathogen reduction technologies.
She has participated in several national and international projects, including the EU-funded COVIRNA project (Horizon 2020) and the Hungarian HU-RIZONT-funded SENTINEL project. Since 2025, she serves as Serbia’s national representative in the Council of Europe’s EDQM Working Group on Blood Transfusion.
She has authored over 100 scientific publications, co-edited the national textbook Transfuziologija (2023), and is a member of ISBT, the Serbian Medical Society, Society of Physicians of Vojvodina, BAVBD, and the Association of Transfusion Medicine Specialists of Serbia.
Associate Professor Jasmina Grujić, MD, PhD, is Director of the Institute for Blood Transfusion of Vojvodina and Associate Professor at the Faculty of Medicine, University of Novi Sad, Serbia. She earned her MD (2003), specialization in transfusion medicine (2010), and PhD in clinical medicine (2015) at the same institution. Since 2025, she holds a subspecialization in Clinical Transfusion Medicine.
Her expertise includes transfusion medicine, donor screening, immunohematology, transfusion-transmitted infections, and transfusion immunology. She is actively involved in HLA genotyping, hemovigilance, donor health, iron metabolism, clinical transfusion outcomes, and infection risk management. Her research further includes platelet function and hemostasis, transfusion-related immunomodulation (TRIM), antimicrobial resistance, next-generation sequencing in transfusion safety, and pathogen reduction technologies.
She has participated in several national and international projects, including the EU-funded COVIRNA project (Horizon 2020) and the Hungarian HU-RIZONT-funded SENTINEL project. Since 2025, she serves as Serbia’s national representative in the Council of Europe’s EDQM Working Group on Blood Transfusion.
She has authored over 100 scientific publications, co-edited the national textbook Transfuziologija (2023), and is a member of ISBT, the Serbian Medical Society, Society of Physicians of Vojvodina, BAVBD, and the Association of Transfusion Medicine Specialists of Serbia.